Twist Historical Income Statement
| TWST Stock | USD 30.75 0.75 2.38% |
Historical analysis of Twist Bioscience income statement accounts such as Interest Expense of 4.3 K, Selling General Administrative of 110.3 M, Total Revenue of 296 M or Gross Profit of 108.3 M can show how well Twist Bioscience Corp performed in making a profits. Evaluating Twist Bioscience income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Twist Bioscience's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Twist Bioscience Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Twist Bioscience Corp is a good buy for the upcoming year.
Twist |
About Twist Income Statement Analysis
Twist Bioscience Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Twist Bioscience shareholders. The income statement also shows Twist investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Twist Bioscience Income Statement Chart
Twist Bioscience Corp Income Statement is one of the three primary financial statements used for reporting Twist's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Twist Bioscience Corp revenue and expense. Twist Bioscience Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Twist Bioscience's Cost Of Revenue is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 1.1 M in 2024, whereas Operating Income is likely to drop (205.2 M) in 2024. Add Fundamental
Total Revenue
Total revenue comprises all receipts Twist Bioscience Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Twist Bioscience Corp. It is also known as Twist Bioscience overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Twist Bioscience's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Twist Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. At this time, Twist Bioscience's Cost Of Revenue is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 1.1 M in 2024, whereas Operating Income is likely to drop (205.2 M) in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 333.3M | 296.6M | 341.1M | 170.8M | Cost Of Revenue | 119.3M | 155.4M | 178.7M | 187.6M |
Twist Bioscience income statement Correlations
Click cells to compare fundamentals
Twist Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Twist Bioscience income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 382K | (1.9M) | (10.4M) | 1.2M | 1.0M | 1.1M | |
| Net Interest Income | 712K | 68K | 3.0M | 14.4M | 16.5M | 17.3M | |
| Interest Income | 1.5M | 435K | 3.1M | 14.4M | 16.5M | 17.3M | |
| Depreciation And Amortization | 1.3M | (935K) | 2.0M | 24.0M | 27.5M | 28.9M | |
| Interest Expense | 787K | 367K | 80K | 5K | 4.5K | 4.3K | |
| Selling General Administrative | 102.1M | 133.4M | 210.5M | 189.7M | 218.2M | 110.3M | |
| Total Revenue | 90.1M | 132.3M | 203.6M | 245.1M | 281.9M | 296.0M | |
| Gross Profit | 28.7M | 51.7M | 84.2M | 89.7M | 103.2M | 108.3M | |
| Other Operating Expenses | 207.7M | 285.6M | 452.6M | 452.0M | 519.8M | 545.8M | |
| Operating Income | (117.6M) | (153.3M) | (249.0M) | (217.2M) | (195.4M) | (205.2M) | |
| Net Income From Continuing Ops | (139.9M) | (152.1M) | (217.9M) | (204.6M) | (184.2M) | (193.4M) | |
| Ebit | (117.6M) | (153.3M) | (249.0M) | (217.2M) | (195.4M) | (205.2M) | |
| Research Development | 43.0M | 69.1M | 120.3M | 106.9M | 122.9M | 129.1M | |
| Ebitda | (116.3M) | (154.2M) | (247.0M) | (193.2M) | (173.9M) | (182.6M) | |
| Cost Of Revenue | 61.4M | 80.6M | 119.3M | 155.4M | 178.7M | 187.6M | |
| Total Operating Expenses | 146.3M | 205.0M | 333.3M | 296.6M | 341.1M | 170.8M | |
| Income Before Tax | (139.5M) | (154.0M) | (228.3M) | (203.5M) | (183.1M) | (192.3M) | |
| Total Other Income Expense Net | (22.0M) | (768K) | 20.7M | (10.9M) | (12.6M) | (11.9M) | |
| Net Income Applicable To Common Shares | (107.7M) | (139.9M) | (152.1M) | (217.9M) | (196.1M) | (186.3M) | |
| Net Income | (139.9M) | (152.1M) | (217.9M) | (204.6M) | (184.2M) | (193.4M) | |
| Income Tax Expense | 382K | (1.9M) | (10.4M) | 1.2M | 1.0M | 1.1M | |
| Reconciled Depreciation | 6.7M | 9.8M | 16.5M | 29.3M | 33.7M | 35.4M |
Currently Active Assets on Macroaxis
When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Twist Stock analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.61) | Revenue Per Share 4.591 | Quarterly Revenue Growth 0.318 | Return On Assets (0.16) | Return On Equity (0.31) |
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.